Researchers have been excited about this new drug, a groundbreaking dual treatment showing significant results in initial trials for body loss . It functions by modulating two systems: GLP-1 and GIP, which , when stimulated, assist influence hunger and boost calorie burn. Initial reports indicate considerable size management and potential benefits